Nicholas Huntington

Prof. Nicholas Huntington is a Research Professor and Head of the Cancer Immunotherapy Laboratory at Monash University’s Biomedicine Discovery Institute. He specializes in natural killer (NK) cell biology, focusing on regulatory mechanisms of IL-15 signaling, NK cell differentiation, and tumor immunity. His work includes drug discovery for cancer immunotherapy and collaborative pharmaceutical research. He leads initiatives like the MIN (Melbourne Immunotherapy Network) and co-founded oNKo-Innate Pty Ltd.

Education: PhD in Biochemistry (University of Melbourne, 2002–2006).

Research Interests: NK cell biology, cancer immunotherapy, cytokine signaling, and drug discovery. His lab develops novel therapies targeting NK cell checkpoints and explores NK cell roles in radiotherapy and tumor microenvironment interactions.

Key Projects:

• Natural Killer Cell Cancer Immunotherapy (2021–2025)
• Next Generation Cell Therapies for Cancer (2019–2023)
• Melanoma_TP53: Targeting MDM Pathway (2022–2024)

Awards:

• Australian Museum Eureka Prize Finalist (2016)
• Cancer Council Victoria Postdoctoral Fellowship (2006)
• Victorian Premier’s Award (2006)

Labs/Teams: Leads the Cancer Immunotherapy Lab and collaborates with WEHI and global institutions. His work aligns with UN SDGs for health and innovation.